The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down substance use cravings too.

Drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by up to 50%, a study found, adding to mounting evidence that the drugs yield health benefits beyond diabetes and weight loss.

Diet and diabetes drugs like Ozempic and Mounjaro could also help people struggling with alcohol and opioid abuse, according to a new study.

Beyond semaglutide, participants in the latest study were using drugs including Eli Lilly’s weight loss and diabetes drug tirzepatide, the active ingredient in Mounjaro, and Novo Nordisk’s liraglutide, which is sold under the brand names Victoza and Saxenda to treat both diabetes and obesity.

Weight loss medications such as Ozempic may be able to cut drug and alcohol abuse in half, according to a new study from the scientific journal Addiction. The research, published Thursday, found

In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb alcohol and opioid addiction. Published in the journal Addiction, this new study saw researchers from Loyola University Chicago sift through more than 1.

New research shows that Ozempic and similar drugs reduce opioid overdoses by 40% and alcohol intoxication by 50% in people with substance use disorders. These medications, often prescribed for diabetes and weight issues,